RIL
TGTX icon

Rothschild Investment LLC’s TG Therapeutics TGTX Stock Holding History

Rothschild Investment LLC’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.4K Buy
433
+144
+50% +$4.29K ﹤0.01% 1545
2025
Q4 		$8.62K Buy
289
+24
+9% +$784 ﹤0.01% 1627
2025
Q3 		$9.57K Sell
265
-15
-5% -$494 ﹤0.01% 1462
2025
Q2 		$10.1K Buy
280
+20
+8% +$745 ﹤0.01% 1214
2025
Q1 		$10.3K Buy
260
+80
+44% +$2.69K ﹤0.01% 1168
2024
Q4 		$5.42K Buy
180
+30
+20% +$861 ﹤0.01% 1323
2024
Q3 		$3.51K Buy
150
+70
+88% +$1.53K ﹤0.01% 1431
2024
Q2 		$1.42K Buy
80
+70
+700% +$1.12K ﹤0.01% 1504
2024
Q1 		$152 Buy
+10
New +$159 ﹤0.01% 1896

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return